Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: Are There Unsuspected Confounders?
J Nucl Med
.
2018 Apr;59(4):713.
doi: 10.2967/jnumed.117.205856.
Epub 2018 Jan 11.
Authors
Monica Finessi
1
,
Daniele G Nicolotti
,
Gianni Bisi
,
Désirée Deandreis
Affiliation
1
Division of Nuclear Medicine Department of Medical Sciences AOU Città della Salute e della Scienza University of Turin, Italy Corso Dogliotti 14, 10126 Torino E-mail: finessimonica@gmail.com.
PMID:
29326359
DOI:
10.2967/jnumed.117.205856
No abstract available
Publication types
Letter
Comment
MeSH terms
Doxorubicin
Fluorodeoxyglucose F18*
Heart
Positron Emission Tomography Computed Tomography*
Substances
Fluorodeoxyglucose F18
Doxorubicin